Betaprol O Eye Drops contain Betamethasone (0.1% w/w) + Ofloxacin (0.3% w/w), a dual-action steroid-antibiotic formulation designed to treat ocular and ear infections associated with inflammation. This combination ensures rapid symptom relief and infection control in a single therapy.
Betamethasone provides potent anti-inflammatory action, reducing redness, swelling, and irritation, while Ofloxacin, a broad-spectrum fluoroquinolone, effectively targets susceptible bacterial pathogens in eye and ear infections.
Clinically, Betaprol O Eye Drops are suitable for conjunctivitis, keratitis, otitis externa, and other inflammatory ocular and ear conditions, ensuring quick patient recovery and enhanced comfort. Its formulation supports optimal dosing and high patient adherence.
From a business perspective, Betaprol O Eye Drops are part of the high-demand steroid-antibiotic segment, widely used in hospitals, ENT clinics, and ophthalmology centers, offering strong prescription demand, repeat orders, and profitable franchise growth.